Washington DC. – Analysts for a recent study have suggested pioneering techniques for detecting differences between immune cells in tumors that could accelerate the development of cancer treatment.
Researchers from the University of Edinburgh analyzed genes from anonymous medical databases of thousands of tumors to identify genes associated with immune cells. The findings of the study are published in the Journal of Cancer Immunology Research.
Scientists have said that this approach could help doctors choose the best treatment for individual patients and predict which tumors are likely to respond to specific therapy.
It could also help focus on the use of immunotherapy – a new form of treatment that uses its own body defenses to fight cancer. This therapy has shown great promise in recent years, but identification of patients who will respond best is a challenge for doctors.
A new approach based on gene analysis facilitates the understanding of the extent of immune cells present in the tumor. These cells could help the body detect and kill cancer when activated by certain drugs, scientists say.
Traditional treatments such as radiology do not discriminate between cell types and attack both cancerous and healthy cells, often leading to side effects.
A source called ImSig – draws the best picture of tumors and allows scientists to study how certain types of immune cells affect the growth of cancer.